Welcome to LookChem.com Sign In|Join Free

CAS

  • or

283173-83-1

Post Buying Request

283173-83-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

283173-83-1 Usage

Description

1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is a chemical compound characterized by a pyrrolidine ring and a benzyl group, featuring bromine and fluorine substituents. 1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is known for its high purity, which makes it a reliable and consistent component in various chemical reactions.

Uses

Used in Pharmaceutical Industry:
1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is used as a building block for the synthesis of various pharmaceuticals. Its high purity and unique structure contribute to the development of new drugs and biologically active compounds, making it a valuable asset in the pharmaceutical industry.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is utilized as a key intermediate in the production of agrochemicals. Its role in creating effective and reliable products highlights its importance in this field.
Used in Fine Chemicals Industry:
1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is also employed in the synthesis of fine chemicals, where its high purity and unique chemical structure are essential for creating specialized compounds with specific applications.
Used in Research and Development:
Due to its high purity and consistency, 1-(4-BROMO-2-FLUOROBENZYL)PYRROLIDINE, 98% MIN. is a sought-after compound for research and development in both the pharmaceutical and agrochemical industries. It serves as a crucial component in the creation of innovative and effective products.

Check Digit Verification of cas no

The CAS Registry Mumber 283173-83-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,3,1,7 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 283173-83:
(8*2)+(7*8)+(6*3)+(5*1)+(4*7)+(3*3)+(2*8)+(1*3)=151
151 % 10 = 1
So 283173-83-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H13BrFN/c12-10-4-3-9(11(13)7-10)8-14-5-1-2-6-14/h3-4,7H,1-2,5-6,8H2

283173-83-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(4-bromo-2-fluorophenyl)methyl]pyrrolidine

1.2 Other means of identification

Product number -
Other names PC7159

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:283173-83-1 SDS

283173-83-1Downstream Products

283173-83-1Relevant articles and documents

Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode

Down, Kenneth,Amour, Augustin,Anderson, Niall A.,Barton, Nick,Campos, Sebastien,Cannons, Edward P.,Clissold, Cole,Convery, Maire A.,Coward, John J.,Doyle, Kevin,Duempelfeld, Birgit,Edwards, Christopher D.,Goldsmith, Michael D.,Krause, Jana,Mallett, David N.,McGonagle, Grant A.,Patel, Vipulkumar K.,Rowedder, James,Rowland, Paul,Sharpe, Andrew,Sriskantharajah, Srividya,Thomas, Daniel A.,Thomson, Douglas W.,Uddin, Sorif,Hamblin, J. Nicole,Hessel, Edith M.

supporting information, p. 13780 - 13792 (2021/09/28)

Optimization of a previously reported lead series of PI3Kδ inhibitors with a novel binding mode led to the identification of a clinical candidate compound 31 (GSK251). Removal of an embedded Ames-positive heteroaromatic amine by reversing a sulfonamide followed by locating an interaction with Trp760 led to a highly selective compound 9 . Further optimization to avoid glutathione trapping, to enhance potency and selectivity, and to optimize an oral pharmacokinetic profile led to the discovery of compound 31 (GSK215) that had a low predicted daily dose (45 mg, b.i.d) and a rat toxicity profile suitable for further development.

Discovery of two clinical histamine H3 receptor antagonists: Trans - N -ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl] cyclobutanecarboxamide (PF-03654746) and trans -3-fluoro-3-[3-fluoro-4- (pyrrolidin-1-ylmethyl)phenyl]- N -(2-methy

Wager, Travis T.,Pettersen, Betty A.,Schmidt, Anne W.,Spracklin, Douglas K.,Mente, Scot,Butler, Todd W.,Howard, Harry,Lettiere, Daniel J.,Rubitski, David M.,Wong, Diane F.,Nedza, Frank M.,Nelson, Frederick R.,Rollema, Hans,Raggon, Jeffrey W.,Aubrecht, Jiri,Freeman, Jody K.,Marcek, John M.,Cianfrogna, Julie,Cook, Karen W.,James, Larry C.,Chatman, Linda A.,Iredale, Philip A.,Banker, Michael J.,Homiski, Michael L.,Munzner, Jennifer B.,Chandrasekaran, Rama Y.

experimental part, p. 7602 - 7620 (2012/01/05)

The discovery of two histamine H3 antagonist clinical candidates is disclosed. The pathway to identification of the two clinical candidates, 6 (PF-03654746) and 7 (PF-03654764) required five hypothesis driven design cycles. The key to success i

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 283173-83-1